JK,

They actually presented this data at two meetings last year and had a NR then. So very unlikley we will get another news release.

RESVERLOGIX REPORTS ON THE BENEFICIAL EFFECTS OF RVX-208 ON GLUCOSE METABOLISM IN PREDIABETES MELLITUS AT THE AMERICAN DIABETES ASSOCIATION'S (ADA) SCIENTIFIC SESSIONS IN BOSTON, MA

Also, a July 2014 NR also put this study in the context of the ASSURE/SUSTAIN post-hoc analysis.

RVX-208 REDUCES MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) SIGNIFICANTLY IN PATIENTS WITH DIABETES MELLITUS

BearDownAZ